Skip to main content

Advertisement

SpringerLink
Log in

Benign Breast Diseases

  • Review Article
  • Published:
Journal of Mammary Gland Biology and Neoplasia Aims and scope Submit manuscript

Abstract

Benign breast diseases have always been neglected in comparison to cancer, despite the fact that there are many more patients with such diseases than patients presenting to a breast clinic for cancer. Like normal breast tissues, benign breast diseases are under a complex system of controls by both systemic hormonal and local factors. In this review, we attempt to present an overview of the latest knowledge concerning the epidemiology, classification, clinical presentation, management, and physiopathology of these disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

Similar content being viewed by others

References

  1. Sitruk-Ware R, Plu-Bureau G. Epidemiology and treatment of benign breast disease: effect of progestins on breast disease. In: Sitruk-Ware R, Mishelle DR Jr., Editors. Progestins and antiprogestins in clinical practice. New-York: Marcel Dekker; 2000. pp. 327–40.

    Google Scholar 

  2. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985;312:146–51.

    Article  PubMed  CAS  Google Scholar 

  3. Hughes LE, Mansel RE, Webster DJT. Aberrations of normal development and involution (ANDI): a new perspective on pathogenesis and nomenclature of benign breast disorders. Lancet 1987;2:1316–9.

    Article  PubMed  CAS  Google Scholar 

  4. Plu-Bureau G, Thalabard JC, Sitruk-Ware R, Asselain B, Mauvais-Jarvis P. Cyclical mastalgia as a marker of breast cancer susceptibility: results of a case-control study among French women. Br J Cancer 1992;65:945–9.

    PubMed  CAS  Google Scholar 

  5. Goodwin PJ, DeBoer G, Clark RM, Catton P, Redwood S, Hood N, Boyd NF. Cyclical mastopathy and premenopausal breast cancer risk. Results of a case-control study. Breast Cancer Res Treat 1995;33:63–73.

    Article  PubMed  CAS  Google Scholar 

  6. Goehring C, Morabia A. Epidemiology of benign breast disease, with special attention to histologic types. Epidemiol Rev 1997;19:310–27.

    PubMed  CAS  Google Scholar 

  7. Hughes LE, Mansel RE, Webster DJT. Benign disorders and diseases of the breast—concepts and clinical management. 2nd ed. W.B. Saunders; 2000. Chap. 2, pp. 7–20.

  8. Parks AG. The microanatomy of the breast. Ann R Coll Surg Engl 1959;25:295–311.

    Google Scholar 

  9. Noguchi S, Yokouchi H, Aihara T, Motomura K, Inaji H, Imaoka S, Koyama H. Progression of fibroadenoma to phyllodes tumor demonstrated by clonal analysis. Cancer 1995;76:1779–85.

    Article  PubMed  CAS  Google Scholar 

  10. Hughes LE, Mansel RE, Webster DJT. Benign disorders and diseases of the breast—concepts and clinical management. 2nd ed. W.B. Saunders; 2000. Chap. 3, pp. 21–34.

  11. La Rosa S, Sessa F, Colombo L, Tibiletti MG, Furlan D, Capella C. Expression of acidic fibroblast growth factor (aFGF) and fibroblast growth factor receptor 4 (FGFR4) in breast fibroadenomas. J Clin Pathol 2001;54:37–41.

    Article  PubMed  Google Scholar 

  12. Dupont WD, Page DL, Parl FF, Vnencak-Jones CL, Plummer WD Jr, Rados MS, Schuyler PA. Long term risk of breast cancer in women with fibroadenoma. New Engl J Med 1994;331:10–15.

    Article  PubMed  CAS  Google Scholar 

  13. Hughes LE, Mansel RE, Webster DJT. Benign disorders and diseases of the breast—concepts and clinical management. 2nd ed. W.B. Saunders; 2000. Chap. 7, pp. 73–94.

  14. Cole-Beuglet C, Soriano RZ, Kurtz AB, Goldberg BB. Fibroadenoma of the breast. Sonomammography correlated with pathology in 122 patients. American Journal of Radiology 1983;140:369–75.

    CAS  Google Scholar 

  15. Mauvais-Jarvis P. Le traitement hormonal des mastopathies bénignes. Bull Cancer 1991;78:365–71.

    PubMed  CAS  Google Scholar 

  16. Kumar S, Mansel RE, Hughes LE, Edwards CA, Scanlon MF. Prediction of response to endocrine therapy in pronounced cyclical mastalgia, using dynamic tests of prolactin release. Clin Endocrinol 1985;23:699–704.

    Article  CAS  Google Scholar 

  17. Hughes LE, Mansel RE, Webster DJT. Benign disorders and diseases of the breast—concepts and clinical management. 2nd ed. W.B. Saunders; 2000. Chap. 9, pp. 123–35.

  18. Hughes LE, Mansel RE, Webster DJT. Benign disorders and diseases of the breast—concepts and clinical management. 2nd ed. W.B. Saunders; 2000. Chap. 6, pp. 61–72.

  19. Cowen PN, Benson EA. Cytological study of fluid from benign breast cysts. Br J Surg 1979;66:209–11.

    Article  PubMed  CAS  Google Scholar 

  20. Angeli A, Bradlow HL, Chasalon FI, Dogliotti L. Biochemistry of breast cyst fluid. Ann N Y Acad Sci 1990;586:1–296.

    Article  Google Scholar 

  21. Hughes LE, Mansel RE, Webster DJT. Benign disorders and diseases of the breast—concepts and clinical management. W.B. Saunders, 2d ed., 2000; chap. 4, pp 35–47.

  22. De Boever J, Vandekerckhove D. Benign breast disease: steroid concentrations. J Steroid Biochem 1982;Abst 338.

  23. Wang DY, Fentiman IS. Epidemiology and endocrinology of benign breast disease. Breast Cancer Res Treat 1985;6:5–39.

    Article  PubMed  CAS  Google Scholar 

  24. Pasqualini JR, Chetrite G. Activity and regulation of sulfatase, sulfotransferase and 17β-hydroxysteroid dehydrogenase in breast cancer. In: Pasqualini JR, Katzenellenbogen BS, Editors. Hormone-dependent cancer. New York: Marcel Dekker; 1996. pp. 21–80.

    Google Scholar 

  25. Pasqualini JR, Cortes-Prieto J, Chetrite G, Talbi M, Ruiz A. Concentrations of estrone, estradiol and their sulfates, and evaluation of sulfatase and aromatase activities in patients with breast fibroadenoma. Int J Cancer 1997;70:639–43.

    Article  PubMed  CAS  Google Scholar 

  26. Martin PM, Kuttenn F, Serment H, Mauvais-Jarvis P. Studies on clinical, hormonal and pathological correlations in breast fibroadenomas. J Steroid Biochem 1978;9:1251–55.

    Article  PubMed  CAS  Google Scholar 

  27. Tseng L, Gusberg SB, Gurpide E. Estradiol receptor and 17β-hydroxysteroid dehydrogenase in normal and abnormal human endometrium. Ann N Y Acad Sci 1977;286:190–8.

    Article  PubMed  CAS  Google Scholar 

  28. Allegra JC, Lippman ME, Green L, Barlock A, Simon R, Thompson EB, Huff KK, Griffin W. Estrogen receptor values in patients with benign breast disease. Cancer 1979;44:228–31.

    Article  PubMed  CAS  Google Scholar 

  29. Martin PM, Kuttenn F, Serment H, Mauvais-Jarvis P. Progesterone receptors in breast fibroadenomas. J Steroid Bioch 1979;11:1295–98.

    Article  CAS  Google Scholar 

  30. Kuttenn F, Fournier S, Durand JC, Mauvais-Jarvis P. Estradiol and progesterone receptors in human breast fibroadenomas. J Clin Endocrinol Metab 1981;52:1225–9.

    Article  PubMed  CAS  Google Scholar 

  31. Ferrieres C, Cuny M, Simony-Fontaine J. Variation of Bcl-2 expression in breast ducts and lobules in relation to plasma progesterone levels: overexpression and absence of variation in fibroadenomas. J Pathol 1997;183:204–11.

    Article  PubMed  CAS  Google Scholar 

  32. Mauvais-Jarvis P, Sitruk-Ware R, Kuttenn F, Sterkers N. Luteal phase insufficiency: a common pathophysiologic factor in development of benign and malignant breast diseases. Comment Res Breast Dis 1979;1:25–59.

    Google Scholar 

  33. England PC, Skinner LG, Cottrell KM, Sellwood RA. Sex hormones in breast disease. Br J Surg 1975;62:806–9.

    Article  PubMed  CAS  Google Scholar 

  34. Peters F, Pickardt CR, Zimmerman G, Breckwoldt M. PRL, TSH and thyroid hormones in benign breast disease. Klin Wochenschr 1981;59:403–7.

    Article  PubMed  CAS  Google Scholar 

  35. Kumar S, Mansel RE, Hughes LE, Woodhead JS, Edwards CA, Scanlon MF, Newcombe RG. Prolactin response to thyrotropin-releasing hormone stimulation and dopaminergic inhibition in benign breast disease. Cancer 1984;53:1311–5.

    Article  PubMed  CAS  Google Scholar 

  36. Gately CA, Maddox PR, Jones DL. Biologically active prolactin in patients with macroscopic breast cysts. Br J Surg 1992;79:1238.

    Google Scholar 

  37. Ginsburg E, Vonderhaar BK. Prolactin synthesis and secretion by human breast cancer cells. Cancer Res 1995;55:2591–5.

    PubMed  CAS  Google Scholar 

  38. Clevenger CV, Chang WP, Ngo W, Pasha TM, Montone KT, Tomaszewski JE. Expression of prolactin and prolactin receptor in human breast carcinoma. Am J Pathol 1995;146:695–705.

    PubMed  CAS  Google Scholar 

  39. Reynolds C, Montone KT, Powell CM, Tomaszewski JE, Clevenger CV. Expression of prolactin and its receptor in human breast carcinoma. Endocrinology 1997;138:5555–60.

    Article  PubMed  CAS  Google Scholar 

  40. Touraine P, Martini JF, Zafrani B, Durand JC, Labaille F, Malet C, Nicolas A, Trivin C, Postel-Vinay MC, Kuttenn F, Kelly PA. Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues. J Clin Endocrinol Metab 1998;83:667–74.

    Article  PubMed  CAS  Google Scholar 

  41. Clevenger CV, Plank TL. Prolactin as an autocrine/paracrine factor in breast cancer. J Mammary Gland Biol Neopl 1997;2:59–68.

    Article  CAS  Google Scholar 

  42. Vonderhaar BK. Prolactin: the forgotten hormone of human breast cancer. Pharmacol Ther 1998;79:169–78.

    Article  PubMed  CAS  Google Scholar 

  43. Goffin V, Touraine P, Pichard C, Bernichtein S, Kelly PA. Should prolactin be reconsidered as a therapeutic target in human breast cancer? Mol Cell Endocrinol 1999;151:79–87.

    Article  PubMed  CAS  Google Scholar 

  44. Llovera M, Touraine P, Kelly PA, Goffin V. Involvement of prolactin in breast cancer: redefining the molecular targets. Exp Gerontol 2000;35:41–51.

    Article  PubMed  CAS  Google Scholar 

  45. Clevenger CV, Furth PA, Hankinson SE, Schuler LA. The role of prolactin in mammary carcinoma. Endocr Rev 2003;24:1–27.

    Article  PubMed  CAS  Google Scholar 

  46. Manhes C, Kayser C, Bertheau P, Kelder B, Kopchick JJ, Kelly PA, Touraine P, Goffin V. Local over-expression of prolactin in differentiating mouse mammary gland induces functional defects and benign lesions, but not carcinoma. J Endocrinol 2006;190:273–87.

    Article  CAS  Google Scholar 

  47. Ryska A, Reynolds C, Keeney GL. Benign tumors of the breast with multinucleated stromal giant cells. Immunohistochemical analysis of six cases and review of the literature. Virchows Arch 2001;439:768–75.

    PubMed  CAS  Google Scholar 

  48. Mol JA, Henzen-Longmans SC, Hageman Ph, Misdorp W, Blankenstein MR, Rijnberk A. Expression of the gene encoding GH in the human mammary gland. J Clin Endocrinol Metab 1995;80:3094–6.

    Article  PubMed  CAS  Google Scholar 

  49. Ng ST, Zhou J, Adesanya OO, Wang J, LeRoith D, Bondy CA. Growth hormone treatment induces mammary gland hyperplasia in aging primates. Nature Medicine 1997;10:1141–4.

    Article  Google Scholar 

  50. Holdaway IM, Mason BH, Lethaby AE, Singh V, Harman JE, MacCormick M, Civil ID. Serum levels of insulin-like growth factor binding protein-3 in benign and malignant breast disease. Aust NZ J Surg 1999;69:495–500.

    Article  CAS  Google Scholar 

  51. Cullen KJ, Smith HS, Hill S, Rosen N, Lippman ME. Growth factor messenger RNA expression by human breast fibroblasts, benign and malignant lesions. Cancer Res 1991;51:4978–85.

    PubMed  CAS  Google Scholar 

  52. Fantl V, Creer A, Dillon C, Bresnick J, Jackson D, Edwards P, Rosewell I, Dickson C. Fibroblast growth factor signaling and cyclin D1 function are necessary for normal mammary gland development during pregnancy. Advances in Experimental Medicine and Biology, vol. 480 “Biology of the mammary gland” 2000. Chap 1, pp. 1–7.

  53. Coombes RC, Gomm JJ, Luqmani YA. Acidic and basic FGF and their receptors in normal and malignant breast cells. Endocrinology 1994;35:259.

    Google Scholar 

  54. Gomm JJ, Smith J, Ryall GK, Baillie R, Turnbull L, Coombes RC. Localization of basic fibroblast growth factor and transforming growth factor β1 in the human mammary gland. Cancer Res 1991;51:4685–92.

    PubMed  CAS  Google Scholar 

  55. Barraclough R, Fernig DG, Rudland PS, Smith JA. Synthesis of basic fibroblast growth factor upon differentiation of rat mammary epithelial to myoepithelial-like cells in culture. J Cell Physiol 1990;144:333–44.

    Article  PubMed  CAS  Google Scholar 

  56. Ethier SP, Van de Velde. Secretion of TGF-β like growth inhibitor by normal rat mammary epithelial cells. J Cell Physiol 1990;142:15–20.

    Article  PubMed  CAS  Google Scholar 

  57. Lippman ME, Dickson RB. Growth control of normal and malignant breast epithelium. Proc R Soc Edinburgh 1989;95b:89–106.

    Google Scholar 

  58. Baillie R, Coombes RC, Smith J. Multiple forms of TGF-β1 in breast tissues: a biologically active form of the small latent complex of TGF-β1. European Journal of Cancer 1996;32A(9):1566–73.

    Article  PubMed  CAS  Google Scholar 

  59. Di Loreto C, Reis FM, Cataldi P, Zuiani C, Luisi S, Beltrami CA, Petraglia F. Human mammary gland and breast carcinoma contain immunoreactive inhibin/activins subunits: evidence for a secretion into cystic fluid. Eur J Endocrinol 1999;141:190–4.

    Article  PubMed  Google Scholar 

  60. Wang Y, Selden C, Morgan N, Stamp GWH, Hodgson HJF. Hepatocyte growth factor/scatter factor expression in human mammary epithelium. Am J Pathol 1994;144:675–82.

    PubMed  CAS  Google Scholar 

  61. Feakins RM, Wells CA, Young KA, Sheaff MT. Platelet-derived growth factor expression in phyllodes tumors and fibroadenomas of the breast. Hum Pathol 2000;31:1214–22.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology and Reproductive Medicine, Paris V University, GH Pitie-Salpetriere, 47/83 Bd de l’Hopital, AP-HP 75651, Paris Cedex 13, France

    Carine Courtillot, Frédérique Kuttenn & Philippe Touraine

  2. Inserm U809 Targets of Peptide Hormones Regulating Fertility, Faculty of Medicine René Descartes, Paris V University, Paris, France

    Nadine Binart

  3. Inserm U808 Prolactin Growth Hormone and Tumors, Faculty of Medicine René Descartes, Paris V University, Paris, France

    Vincent Goffin

  4. Department of Radiology, Institut Gustave Roussy, Villejuif, France

    Corinne Balleyguier

  5. Department of Pathology, Institut Curie, Paris, France

    Brigitte Sigal-Zafrani

  6. Department of Reproductive Medicine and Gynecology, Paris V University Hotel Dieu Hospital, AP-HP Paris Notre Dame, Paris, France

    Geneviève Plu-Bureau

  7. Inserm U808 Hormone Targets, Faculty of Medicine René Descartes, Paris V University, Paris, France

    Frédérique Kuttenn & Philippe Touraine

  8. Inserm U808-809 Hormone Target, Faculty of Medicine René Descartes, Paris V University, Paris, France

    Paul A. Kelly

Authors
  1. Carine Courtillot
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Geneviève Plu-Bureau
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nadine Binart
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Corinne Balleyguier
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Brigitte Sigal-Zafrani
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Vincent Goffin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Frédérique Kuttenn
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Paul A. Kelly
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Philippe Touraine
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Philippe Touraine.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Courtillot, C., Plu-Bureau, G., Binart, N. et al. Benign Breast Diseases. J Mammary Gland Biol Neoplasia 10, 325–335 (2005). https://doi.org/10.1007/s10911-006-9006-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10911-006-9006-4

Keywords

Search

Navigation